RHOA and neoplasm: Treating the RhoA-CA-transfected MTF7 cells with cytochalasin D completely disrupted their SF actin filaments (Figure 4i,j) and periFN assembly (Figure 4k,l), suggesting that SF actin cytoskeleton mediates the RhoA-activated periFN matrix assembly on adherent tumor cells.